Morgan Stanley’s Actuate Therapeutics, Inc. Common stock ACTU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$47.3K Buy
7,740
+6,202
+403% +$37.9K ﹤0.01% 6376
2025
Q1
$10.4K Buy
1,538
+996
+184% +$6.74K ﹤0.01% 6784
2024
Q4
$4.31K Buy
+542
New +$4.31K ﹤0.01% 7044